Profil
Louise Armstrong-Denby is an Independent Director at CellaVision AB since 2023.
Prior to this, she was the Global Sales Director at Andor Technology Ltd. and the Chief Commercial Officer at Visiopharm A from 2019 to 2023.
She also served as the Chief Sales Officer at Random42 Ltd.
Aktive Positionen von Louise Armstrong-Denby
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLAVISION AB | Direktor/Vorstandsmitglied | 01.01.2023 |
Ehemalige bekannte Positionen von Louise Armstrong-Denby
| Unternehmen | Position | Ende |
|---|---|---|
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Corporate Officer/Principal | 01.01.2023 |
| ANDOR TECHNOLOGY PLC | Vertrieb & Marketing | - |
Random42 Ltd.
Random42 Ltd. Movies/EntertainmentConsumer Services Provides digital solutions to pharmaceutical and biotech sectors | Vertrieb & Marketing | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
CellaVision AB
CellaVision AB Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
Andor Technology Ltd.
Andor Technology Ltd. Computer PeripheralsElectronic Technology Develops and manufactures digital cameras and glasses | Electronic Technology |
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Technology Services |
Random42 Ltd.
Random42 Ltd. Movies/EntertainmentConsumer Services Provides digital solutions to pharmaceutical and biotech sectors | Consumer Services |
















